CCNA2 and cholangiocarcinoma: A previous study in the cholangiocarcinoma cell line also pointed to CP’s efficacy to decrease the expression of cyclin A and Cdc25; which are responsible for G2 to mitosis (M) phase transition, resulting in G2/M cell cycle arrest [17].